|
|
Correlation of CD4+ T cell count and hepatitis B virus replication, neutrophil- to-lymphocyte ratio in human immunodeficiency virus/hepatitis B virus co-infected patients |
YANG Yang LIU Fudi ZENG Fanglin |
Department of Laboratory Medicine, Affiliated Hospital of Yangzhou University, Jiangsu Province, Yangzhou 225000, China
|
|
|
Abstract Objective To investigate the correlation of CD4+ T cell count and hepatitis B virus (HBV) replication, neutrophil- to-lymphocyte ratio (NLR) in human immunodeficiency virus (HIV)/HBV co-infected patients. Methods The clinical data of 59 patients with HBV simplex infection (HBV group) and 76 patients with HIV/HBV co-infection (HIV/HBV group) admitted to the Affiliated Hospital of Yangzhou University from February 2018 to January 2022 were retrospectively analyzed. According to CD4+T cell count, the HIV/HBV group was divided into group A (CD4+T cell count>200 /μl, 31 cases) and group B (CD4+T cell count≤200 /μl, 45 cases). The CD4+T cell count, HBV DNA level, and NLR were compared between HBV group and HIV/HBV group, and the HBV DNA level and NLR were further compared between group A and group B, and the correlation between the CD4+T cell count and HBV DNA level, NLR was analyzed in HIV/HBV co-infected patients. Results CD4+T cell count and HBV DNA level in HIV/HBV group were lower than those in HBV group, while NLR was higher than that in HBV group, the differences were statistically significant (P<0.05). The HBV DNA level and NLR in group A were lower than those in group B, the differences were statistically significant (P<0.05). CD4+T cell count was negatively correlated with HBV DNA level and NLR in HIV/HBV group (r<0, P<0.05). Conclusion In HIV/HBV co-infected patients, CD4+T cell count is decreased and HBV DNA replication is more active, which has important significance for clinical drug guidance.
|
|
|
|
|
[1] 韩静,蒋忠胜,王刚,等.广西人类免疫缺陷病毒感染者/艾滋病患者合并马尔尼菲篮状菌感染的特征及Mp1p抗原快速筛检的研究[J].微生物与感染,2021,16(1):19-25.
[2] 何小清,沈银忠,陆凤茹,等.人类免疫缺陷病毒/艾滋病患者心电图特征和异常率分析[J].中华传染病杂志,2019, 37(12):748-753.
[3] 陈坚,柳智豪,梁旭,等.艾滋病抗病毒治疗对配偶间人类免疫缺陷病毒传播的影响分析[J].中国现代医学杂志,2017,27(3):64-68.
[4] 谢铭,吴大洲,柳娟,等.19067例无偿献血志愿者HBV、HIV感染筛查结果分析[J].广西医科大学学报,2021,38(11):2190-2195.
[5] 聂源,兰芸,李锋,等.HBeAg状态对HIV/HBV合并感染者免疫重建的影响[J].国际流行病学传染病学杂志,2018, 45(5):293-296.
[6] 蒋琴,毛德文,胡振斌,等.解毒化瘀颗粒治疗HIV合并重型HBV患者的临床研究[J].中西医结合肝病杂志,2017, 27(6):328-330.
[7] 林厚雄,王德志,黄修柳.HIV合并HBV感染者T淋巴细胞亚群血浆病毒载量与肝脏功能的关系[J].中国艾滋病性病,2022,28(1):70-73.
[8] 兰青,韦嘉,范晶华,等.HIV/HBV合并感染者经含拉米夫定的HAART治疗后YMDD变异[J].昆明医科大学学报,2015,36(6):163-167,184.
[9] 刘钊,李俊红.HIV/AIDS合并感染乙型/丙型肝炎病毒患者肝功能损伤情况分析[J].中国临床医生杂志,2019,47(12):1407-1409.
[10] 李莹莹,李婷,张铭,等.CD4+T淋巴细胞计数在慢性肾衰竭患者衰弱状态评价中的监测意义[J].临床荟萃,2022,37(3):243-247.
[11] 李雪,丁艳,黄玲,等.HIV/TB并发感染患者外周血T淋巴细胞表达及与HIV RNA载量的相关性研究[J].现代检验医学杂志,2022,37(1):88-91,124.
[12] 雷佩茹,李迎杰,李静.非酒精性脂肪性肝病合并2型糖尿病患者同型半胱氨酸水平和中性粒细胞与淋巴细胞比值的临床意义[J].临床肝胆病杂志,2021,37(10):2352-2356.
[13] 中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南第三版(2015版)[J].中华临床感染病杂志,2015,8(5):385-401.
[14] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版)[J].中国肝脏病杂志(电子版),2015(5):1-18.
[15] 杨蓉蓉,桂希恩,熊勇,等.CD4+T淋巴细胞水平对HIV合并HBV感染患者HBV病毒复制及肝病的影响[J].中华全科医师杂志,2016,15(6):466-468.
[16] 陈民,徐小国,司进枚,等.艾滋病合并肺结核患者CD4+T淋巴细胞与肺结核类型的关系[J].中国性科学,2021, 30(1):143-145.
[17] 陈念,柯柳,温小凤,等.拉米夫定联合其他药物对HIV/ HBV合并感染者的抗HBV效果分析[J].热带病与寄生虫学,2018,16(1):12-14,30.
[18] 陈念,柯柳,苏明华,等.HIV/HBV合并感染者的HBeAg状态与免疫重建的关系[J].中国皮肤性病学杂志,2019, 33(10):1158-1160.
[19] 孙敏,张冉,罗叶,等.2119例HIV/AIDS病例首次CD4+T淋巴细胞检测结果及影响因素分析[J].国际检验医学杂志,2022,43(4):479-484,490.
[20] 冯永亮,常越,石璟,等.不同CD4+T淋巴细胞水平的HIV感染者乙型肝炎疫苗免疫效果及持久性研究[J].中华流行病学杂志,2021,42(9):1559-1565.
[21] 朱晗,卢洪洲.老年HIV感染者抗病毒治疗后CD4+T淋巴细胞增长的影响因素分析[J].临床内科杂志,2021, 38(4):240-243.
[22] 凌淳,李媛媛.40岁以上HBeAg阴性慢性乙肝患者血清HBV DNA水平与肝纤维化的关系探讨[J].贵州医药,2022,46(1):27-28.
[23] 吕岳峰,朱志斌,黄升中,等.HBsAg ELISA阴性血液中HBV DNA、HBVNRAg检测情况及HBV基因变异分析[J].实用预防医学,2017,24(6):662-665.
[24] 李彩东,陈锡莲,田鹏飞,等.慢性乙型肝炎患者外周血中T淋巴细胞亚群和CD4+CD25+调节性T淋巴细胞的表达水平与HBV DNA定量的相关分析[J].临床肝胆病杂志,2015(4):541-545.
[25] 彭真,靳慧鸣,宁会彬,等.淋巴细胞亚群检测对抗病毒治疗的慢性乙型肝炎患者HBsAg下降的预测价值[J].临床肝胆病杂志,2021,37(9):2071-2074.
[26] 常谦,孟宪春,杨若男,等.血小板淋巴细胞比值与中性粒细胞淋巴细胞比值在HBV、HCV感染者中的临床意义评价[J].东南大学学报(医学版),2016,35(6):854-860.
[27] 杨娜,何华,赵天业,等.红细胞分布宽度/血小板比值、血小板/淋巴细胞比值、中性粒细胞/淋巴细胞比值对慢性丙型肝炎肝硬化代偿期的预测价值[J].临床肝胆病杂志,2021,37(6):1319-1325.
[28] 陈念,柯柳,苏明华,等.HIV/HBV合并感染患者的CD4+T淋巴细胞计数与HBV DNA的关系[J].热带病与寄生虫学,2019,17(2):111-112. |
|
|
|